Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sage Park is a global investment firm that specializes in acquiring and operating businesses across several key sectors, including life sciences, healthcare, and industrial manufacturing. The firm focuses on complex divestitures and corporate carve-outs, providing operational expertise to drive growth and efficiency within its portfolio companies. In the life sciences space, Sage Park is notable for its acquisition of Sancilio & Company, a biopharmaceutical firm focused on lipid-based drug delivery and specialized therapeutics. The firm's approach combines capital investment with hands-on operational management to revitalize and scale businesses in the healthcare and biotech industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sage Park.